IMA vs VICI · rev $9.2M vs P/E 9.3, rev $3.85B
ImageneBio, Inc. (IMA) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported VICI revenue for 2024-12-31 was $3.85B. Net income was $2.72B. Revenue was up 6.6% from 2023-12-31 to 2024-12-31. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
IMA currently screens at market cap $64.7M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the IMA and VICI stock pages for the full models.
Not investment advice.